Novartis AGNVSNYSE
Loading
P/E Ratio HistoryNormalizing
Percentile Rank50
3Y CAGR-13.6%
5Y CAGR-7.2%
Studio
Year-over-Year Change

Price-to-earnings ratio

3Y CAGR
-13.6%/yr
vs +19.5%/yr prior
5Y CAGR
-7.2%/yr
Recent deceleration
Acceleration
-33.1pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthNormalizing
PeriodValueYoY Change
202518.30+10.9%
202416.51+16.2%
202314.20-49.9%
202228.35+245.1%
20218.22-69.2%
202026.65+43.9%
201918.53+33.2%
201813.91-38.8%
201722.73-0.1%
201622.77-